Expert: Pharmacy, Medical Benefit Adoption of Biosimilars Present Different Challenges
May 2nd 2023Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the biosimilars landscape and where biosimilars fall in the process of pharmacy and medical benefit adoption.
Pharmacists Will Have a Very Important Role in Psychedelic Medicine for Patients With Cancer
April 21st 2023As psychedelic medicine comes further into cancer care, pharmacists will be an important part of the interdisciplinary team in screening and evaluating patients for suitability for psychedelic medicine.
Psychedelic-assisted Therapy Is More Analogous to Oncology Care Than Traditional Mental Health Care
April 14th 2023The Aquilino Cancer Center established the Bill Richards Center for Healing inside the same building, so patients with cancer can receive psychedelic-assisted therapy in the same location as their cancer care.
Encourage Patients to Call Between Visits for Better Toxicity Management During Treatment
April 7th 2023It would also be beneficial to include a patient’s entire healthcare team in this management strategy, said an expert at the Hematology/Oncology Pharmacy Association (HOPA) Annual Conference 2023 in Phoenix, Arizona.
The Hematology/Oncology Pharmacy Association Makes Purposeful Strides Towards Inclusive Care
March 31st 2023The Hematology/Oncology Pharmacy Association (HOPA) created committees, inclusion statements, and diversity, equity, and inclusion (DEI) checkpoints to improve healthcare for underserved or historically less included populations.
Pharmacists Need to Be An Advocate, Recognized as Integral to Care Teams
March 29th 2023President (2022 to 2023) of the Hematology Oncology Pharmacists Association (HOPA) highlights the many ways that hematology/oncology pharmacists can collaborate with care teams to improve access to care at HOPA Annual Conference 2023 in Phoenix, Arizona from March 29 to April 1.